You just read:

Glenmark Pharmaceuticals Announces Presentation of New Subtype Analysis of GBR 830, an Investigational, Anti-OX40 Monoclonal Antibody, at the American Academy of Dermatology Annual Meeting

News provided by

Glenmark Pharmaceuticals

Mar 01, 2019, 10:00 ET